Colchicine in Patients with Chronic Coronary Disease

In RCT (n=5522), after median follow-up of 28.6 months, risk of CV events was significantly lower among those who received 0.5 mg of colchicine once daily than among those who received placebo (event rate 6.8% vs. 9.6%; HR 0.69; 95% CI, 0.57 to 0.83; p<0.001)


New England Journal of Medicine